Pfizer will absorb Mylan to create new global pharmaceutical company

PITTSBURGH — Pfizer announced Monday it will absorb Canonsburg-based Mylan with Upjohn, the company's off-patent branded generic business, Mylan said in a press release.

The two will create a new global pharmaceutical company.

Upjohn, makes medications Lipitor, Celebrex and Viagra. Mylan is best known for its EpiPen, an injector used to halt life-threatening allergic reactions.

You can now customize your WPXI News App to receive news alerts. CLICK HERE to find out how.

Pfizer shareholders will own a majority of the combined company, according to a press release on Mylan’s website.

The boards of directors for both companies have unanimously approved the agreement.

The deal Monday arrives at a precarious time for big drug makers who are threatened by patent protection losses and lower-priced rivals.

>>PREVIOUS: Lawsuit alleges Mylan, other pharma companies conspired to inflate drug prices

The new company will be incorporated in Delaware and run operations in Pittsburgh, Shanghai and Hyderabad, India.

The combination is expected to close in the middle of next year.

We're continuing to follow this developing story. Refresh WPXI.com for updates. 

The Associated Press contributed to this report. 

TRENDING NOW:

Cox Media Group